The FOCUS Communications Service Provider Index (CSPI) was barely in the black for this current period with a three-month gain of 1.0%.This lagged both the 8.2% gain in the S&P 500 and the 9.5% gain in the NASDAQ over the same time frame by a wide margin.The situation is similar for the full year period as the CSPI’s increase of 16.5% represents less than half of the annual gains of the S&P 500 (up 38.6%) and the NASDAQ (up 44.2%). Sector multiples are higher than at this same time last year and closed out the period at 3.1x revenue and 8.7x EBITDA. Year-ago multiples were only 2.7x revenue and 7.8x EBITDA.
The first quarter of 2021 delivered 38 reported behavioral health transactions, an increase over any quarter in 2020. We expect some of this activity reflects deals that were delayed due to COVID-19. However, we generally expect high deal flow throughout 2021, supported by increasing private equity interest, a favorable government, and a seller pool that is ready to transact.
Once again, the FOCUS Telecom Business Services Index (TBSI) climbed higher, gaining 3.5% over the past three months. This marks the fifth straight period with a positive return for the sector. However, the TBSI did lag
the broader indices as the S&P 500 was up 8.2% and the NASDAQ was up 9.5% over the same time period. When looked at over the past 12 months, the sector’s return compares more favorably to the overall market. The 43.3% year-over-year gain in the TBSI outperforms the 38.6% gain in the S&P 500 and falls just shy of the 44.2% gain in the NASDAQ. Sector multiples are also higher than at this same time last year and closed out the period at 0.7x revenue and 9.6x EBITDA. This compares to year-ago multiples of 0.6x revenue and 7.4x EBITDA.
Founded in 2017 and based in Houston, BlueSprig Pediatrics is already one of the largest and fastest- growing ABA (Applied Behavior Analysis) therapy providers in the country. It is the largest autism services provider in Texas and the Southeast, with over 40 centers in Texas, and now has centers in 18 states, from Illinois and Massachusetts to Oregon and Washington. BlueSprig’s mission is to “change the world for children with autism” and it is “committed to providing compassionate, individualized, and evidence-based behavior analysis treatment.”
M&A Worldwide recently conducted an interview with two bankers from FOCUS Investment Banking to gain insight into the practice and workings of the Advanced Manufacturing sector.
The FOCUS Carrier-Focused Telecom Technology Index (CFTTI) enjoyed yet another strong reporting period with a three-month gain of 13.1%. Not only was this gain impressive in absolute terms, but it handily outperformed both the 10.3% gain in the S&P 500 and the 4.2% gain in the NASDAQ over the same time period.The CFTTI still lags the broader indices for the full year period as its 18.6% gain in the last 12-months compares unfavorably to both the 38.1% gain in the S&P 500 and the 44.9% gain in the NASDAQ. Sector multiples ended the period at 2.6x revenue and 12.8x EBITDA. Both of these are higher than year-ago multiples of 2.4x revenue and 11.7x EBITDA.
EyeSouth is One of the Most Active Ophthalmology Practice Management Companies with 23 Acquisitions Since 2017
We profile investors to provide our clients with an important understanding of the types of private equity firms, independent investors, and family offices active in the healthcare verticals we work in every day. Although it is not feasible to create case studies for every investor, we profile those that represent the most active practices common in today’s acquisition market.
Designed to help physician owners considering a sale to private equity, this paper examines the key questions common to our initial client conversations. The learnings apply to all practice verticals from ophthalmology .. to gastroenterology .. to dermatology. Topics include: The Best Time to Sell, Determining the Best Buyer, The Private Equity Investment Model, Calculating Adjusted EBITDA for Medical Practices, Practice Valuation and Multiples, How to Get Associate Physicians to Buy-in.
The M&A market for companies in the Salesforce Partners program is reaching a critical inflection point. Competition is growing more intense, as the number of available firms shrinks, raising already-high valuations for those that remain independent. At the same time, proposed capital gains tax hikes make it imperative for potential sellers to consider doing deals as soon as possible.
The FOCUS Enterprise-Focused Telecom Technology Index (EFTTI) cooled off significantly this past three months but still managed to turn in a positive return of 2.2%. This lagged both the 12.6% gain in the S&P 500 and the 6.8% gain in the NASDAQ by fairly wide margins.The sector is still up a hefty 48.4% over the past year, which puts its performance roughly in the middle of the 43.6% gain in the S&P 500 and the 57.1% gain in the NASDAQ over the corresponding time frame. Sector multiples are also significantly higher than they were a year ago. The sector revenue multiple jumped from 4.0x to 6.3x, while the sector EBITDA multiple increased from 16.0x to 24.6x.
The first quarter of 2021 delivered 38 reported behavioral health transactions, an increase over any quarter in 2020. We expect some of this activity reflects deals that were delayed due to COVID-19. However, we generally expect high deal flow throughout 2021, supported by increasing private equity interest, a favorable government, and a seller pool that is ready to transact. 
Founded in 2017 and based in Houston, BlueSprig Pediatrics is already one of the largest and fastest- growing ABA (Applied Behavior Analysis) therapy providers in the country. It is the largest autism services provider in Texas and the Southeast, with over 40 centers in Texas, and now has centers in 18 states, from Illinois and Massachusetts to Oregon and Washington. BlueSprig’s mission is to “change the world for children with autism” and it is “committed to providing compassionate, individualized, and evidence-based behavior analysis treatment.” 
Designed to help physician owners considering a sale to private equity, this paper examines the key questions common to our initial client conversations. The learnings apply to all practice verticals from ophthalmology .. to gastroenterology .. to dermatology. Topics include: The Best Time to Sell, Determining the Best Buyer, The Private Equity Investment Model, Calculating Adjusted EBITDA for Medical Practices, Practice Valuation and Multiples, How to Get Associate Physicians to Buy-in. 
